CNTMF - Cansortium Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Cansortium Inc.

82 North East 26th Street
Suite 110
Miami, FL 33137
United States
305-902-2720
http://www.cansortium.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jose Javier HidalgoCEO & DirectorN/AN/AN/A
Mr. Henry BatievskyCFO & DirectorN/AN/AN/A
Mr. Patrick MaloyCOO & DirectorN/AN/AN/A
Dr. Jennifer McCafferty-FernandezChief Science OfficerN/AN/AN/A
Mr. Jeffrey ReathExec. VP of Fin. & Investor Relations Corp. Sec. and DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. It operates cultivation, processing, and dispensary facilities in Florida, Texas, and Puerto Rico; and a dispensary license in Pennsylvania. The company was founded in 2015 and is headquartered in Miami, Florida.

Corporate Governance

Cansortium Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.